EGFR Gene Signature May Predict Prognosis and Guide Treatment in Lung Cancer

EGFR Gene Signature May Predict Prognosis and Guide Treatment in Lung Cancer

The BATTLE I trial is part of a set of studies that are examining the genetic profiles of individual tumors and then assigning therapies that offer the best benefits on the basis of the tumor's unique characteristics. "The EGFR-mutation signature will be evaluated as a predictor of response in the BATTLE I trial," said Dr. Saintigny, adding that they will be presenting those results later this year at the annual meeting of the American Society of Clinical Oncology.

POST COMMENT

a better choice for treatments of ovarian cyst The Panic Away Treatment Method By Mc Donagh Esophageal Cancer Chemotherapy Esophageal Cancer Metastasis, Best Natural Remedies Stage Iv Esophageal Cancer, Natural Cure For Cancer Two Most Common Types Of Esophageal Cancer, Natural Remedies Asbestos Exposure Cancer And Lymphoid Structures Chiropractor Flushing Ny | Leg Pain Causes And Common Treatments How To File Mesothelioma Lawsuits Without Loopholes Cures For Peritoneal Mesothelioma And Their Reliability What Peritoneal Mesothelioma Holds For A Patient Peel apples are anti. Anti-oxidant protect cancer Cabbage anti Cancer